adamantane has been researched along with Neurodegenerative Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandrova, A; Bibi, A; Dragomanova, S; Georgieva, A; Kalfin, R; Lazarova, M; Munkuev, A; Reynisson, J; Salakhutdinov, N; Stefanova, M; Suslov, E; Tancheva, L; Tzvetanova, E; Uzunova, D; Volcho, K | 1 |
| Dembitsky, VM; Gloriozova, TA; Poroikov, VV | 1 |
| Baazaoui, N; Iqbal, K | 1 |
| Ahn, JY; Cho, SW; Choi, J; Choi, SY; Han, AR; Kim, EA | 1 |
1 review(s) available for adamantane and Neurodegenerative Diseases
| Article | Year |
|---|---|
Pharmacological profile of natural and synthetic compounds with rigid adamantane-based scaffolds as potential agents for the treatment of neurodegenerative diseases.
Topics: Adamantane; Animals; Halogens; Humans; Neurodegenerative Diseases; Neuroprotective Agents | 2020 |
3 other study(ies) available for adamantane and Neurodegenerative Diseases
| Article | Year |
|---|---|
New Myrtenal-Adamantane Conjugates Alleviate Alzheimer's-Type Dementia in Rat Model.
Topics: Acetylcholinesterase; Adamantane; Alzheimer Disease; Animals; Antioxidants; Bicyclic Monoterpenes; Maze Learning; Neurodegenerative Diseases; Neuroprotective Agents; Norepinephrine; Oxidative Stress; Rats; Rats, Wistar; Scopolamine; Serotonin | 2022 |
Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
Topics: Adamantane; Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Cognition Disorders; Disease Models, Animal; Drug Administration Schedule; Female; Mice; Mice, Transgenic; Mutation; Neurodegenerative Diseases; Neuroprotective Agents; Oligopeptides; Presenilin-1; Recognition, Psychology; tau Proteins; Tauopathies | 2017 |
Anti-inflammatory mechanisms of N-adamantyl-4-methylthiazol-2-amine in lipopolysaccharide-stimulated BV-2 microglial cells.
Topics: Adamantane; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Movement; Hydrogen Peroxide; Interleukin-1beta; Lipid Peroxidation; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Microglia; NADPH Oxidases; Neurodegenerative Diseases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Thiazoles; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |